Workflow
options trading
icon
Search documents
This Oil & Gas Stock is Ready to Make a Move
Schaeffers Investment Research· 2025-06-13 15:44
Group 1: Options Trading Insights - The recommended September call option has a leverage ratio of 7.5 and will double on a 13.6% gain in the underlying security [1] - A front-month gamma-weighted Schaeffer's open interest ratio (SOIR) above 1.00 may indicate an immediate pending move [1] - The Schaeffer's Volatility Index (SVI) is in the 19th percentile of its annual range, suggesting options are a preferred trading route [1] Group 2: ONEOK, Inc. Stock Analysis - ONEOK, Inc. (NYSE:OKE) is attempting to establish a low at its 2020 highs, 2024 summer lows, and spring 2025 lows [2] - The shares are maintaining open interest (OI) balance at the 80-strike, with a previous low found at the peak put 75 strike in April [2] Group 3: Options Trading Services - Subscribers to Schaeffer's Weekend Trader received commentary on OKE along with detailed options trade recommendations [3] - OKE options are currently affordably priced, indicating potential for movement [3] - The service aims to provide structured plans with clear entry and exit points for traders [4]
Signal: This Semiconductor Stock Has Room to Run
Schaeffers Investment Research· 2025-06-13 15:22
AVGO's options are cheap and the stock is not far off record highsThis commentary first appeared on Forbes Great Speculations, where Schaeffer's Investment Research is a regular contributor.Chipmaker Broadcom Inc (NASDAQ:AVGO) has had a busy month. The semiconductor company cleared the $1 trillion market cap level on the way to a record high of $265.43 on June 4. One day later though, AVGO gapped lower by 5%, after the company’s fiscal-year revenue forecast fell short of estimates. The shares have battled b ...
Is the Options Market Predicting a Spike in Kura Oncology Stock?
ZACKS· 2025-06-12 13:51
Company Overview - Kura Oncology, Inc. (KURA) is currently experiencing significant activity in the options market, particularly with the July 18, 2025 $2.50 Put option showing high implied volatility, indicating potential for a major price movement [1][3] Analyst Sentiment - Kura Oncology holds a Zacks Rank 3 (Hold) within the Medical - Biomedical and Genetics industry, which is in the top 30% of the Zacks Industry Rank [3] - Over the past 60 days, four analysts have raised their earnings estimates for the current quarter, while one has lowered theirs, resulting in a shift in the Zacks Consensus Estimate from a loss of $0.62 per share to a profit of $0.21 per share [3] Options Market Insights - The high implied volatility surrounding Kura Oncology suggests that options traders anticipate a significant price movement, which could be indicative of an upcoming event that may lead to either a rally or a sell-off [2][4] - Seasoned options traders often seek out high implied volatility options to sell premium, aiming to benefit from the decay of the option's value if the underlying stock does not move as much as expected by expiration [4]
Biotech Stock for Options Bears to Target Right Now
Schaeffers Investment Research· 2025-06-11 18:41
Core Viewpoint - Crispr Therapeutics Inc's stock rally in June is showing signs of reversal, with shares down 0.6% at $42.69, indicating a potential end to a seven-day winning streak and a historically bearish signal on the charts [1]. Group 1: Stock Performance - The stock has approached its 260-day moving average, currently within 0.75 of the trendline's 20-day average true range (ATR), after spending at least 80% of the last 10 days and two months below this average [2]. - Historical data shows that after similar signals in the past three years, CRSP was lower one month later 80% of the time, averaging an 8% loss, which could bring shares below the $40 level [3]. Group 2: Options Activity - There has been significant bullish activity in options for Crispr Therapeutics, with a ratio of 14.50 calls bought for every put in the last two weeks, indicating a higher level of optimism than 99% of readings from the past year [5].
Software Stock Eyes Worst Day Since April After Earnings
Schaeffers Investment Research· 2025-06-11 14:42
Shares of GitLab Inc (NASDAQ:GTLB) are deep in the red this morning, off 10% at $43.68, after software company's disappointing second quarter and full-year guidance overshadowed a first-quarter earnings beat. No fewer than 14 brokerages have chimed in price-target cuts, the steepest coming from JPMorgan Securities to $52 from $58.Today's bear gap has the software stock eyeing its worst single-session drop since April 3. With a now 22% year-to-date deficit, shares of GTLB remain under the pressure of the ove ...
Chewy Stock Eyes Worst Day Since 2023 After Profit Miss
Schaeffers Investment Research· 2025-06-11 14:32
Pet e-tailer Chewy Inc (NYSE:CHWY) reported a first-quarter earnings miss before the open, overshadowing its revenue beat. The company issued a lackluster full-year outlook, too, despite recent customer growth. At last check, CHWY was down 11.3% to trade at $40.63. Shares are now on track for their third-straight loss, as well as their worst day since August 2023. The equity is pulling back from its June 6, two-year high of $48.62, but support from the 40-day moving average could contain today's losses. For ...
Time To Invest In Limoneira
Seeking Alpha· 2025-06-10 16:54
The Pioneer Of Seeking Alpha's BAD BEAT Investing, Quad 7 Capital is a team of 7 analysts with a wide range of experience sharing investment opportunities for nearly 12 years. They are best known for their February 2020 call to sell everything & go short, & have been on average 95% long 5% short since May 2020. The broader company has expertise in business, policy, economics, mathematics, game theory, & the sciences. They share both long & short trades & invest personally in equities they discuss within the ...
Is the Options Market Predicting a Spike in Elanco Animal Health Stock?
ZACKS· 2025-06-09 13:51
Company Overview - Elanco Animal Health Incorporated (ELAN) is currently experiencing significant activity in the options market, particularly with the Jan 16, 2026 $3.00 Call option showing high implied volatility, indicating potential for a major price movement [1] Market Sentiment - The high implied volatility suggests that investors are anticipating a significant price change for Elanco Animal Health shares, which could be driven by an upcoming event [2][4] - Analysts have a mixed outlook on Elanco, with the company holding a Zacks Rank 3 (Hold) in the Medical - Outpatient and Home Healthcare industry, which is in the top 26% of the Zacks Industry Rank [3] Earnings Estimates - Over the past 60 days, there have been no increases in earnings estimates for the current quarter, while six analysts have lowered their estimates, resulting in a decrease of the Zacks Consensus Estimate from earnings of 25 cents per share to 20 cents [3]
Adobe Reports After Close 6/12 — Options Expire The Next Day
Forbes· 2025-06-06 18:05
Group 1 - The next earnings date for Adobe is projected to be June 12, with earnings estimates of $4.97 per share and revenue of $5.80 billion [1] - Adobe has demonstrated impressive long-term earnings per share growth and revenue growth [4] - Earnings reports can lead to significant volatility in Adobe's stock, which may attract options traders, especially with options expiring on June 13 [5]
Lululemon Stock Eyes Worst Day Since 2020 After Earnings
Schaeffers Investment Research· 2025-06-06 14:54
Core Insights - Lululemon Athletica Inc's stock has dropped 19.7% to $265.71 due to fiscal second-quarter and full-year guidance that missed expectations, primarily attributed to tariff pressures [1] - The stock is experiencing its worst day since March 2020, reaching its lowest level since April and breaking below the $310 support level [2] - Year-to-date, Lululemon has lost 30% of its value, with short interest accounting for 5.4% of the equity's available float [2] Price Target Adjustments - At least 12 brokerages have reduced their price targets for Lululemon, with BMO making the most significant cut from $302 to $250 [1] Options Activity - Today's options activity shows 46,000 calls and 26,000 puts traded, which is 24 times the typical volume [3] - The most popular option is the weekly 6/6 260-strike put, with positions being opened ahead of expiration [3] Sentiment Indicators - Lululemon's put/call open interest ratio (SOIR) stands at 1.31, placing it in the 97th percentile of annual readings, indicating heightened pessimism among short-term options traders [4] - The company has historically exceeded options traders' volatility expectations, reflected in a Schaeffer's Volatility Scorecard (SVS) of 96 out of 100 [4]